Nice find! I'd say they've finished the initial Question and Answer part of the Trials, CEO said they we're on the 2nd list of Questions and what you found means that part been done and ready to start the next Phase - That'll start the intrest here - Good Find
So, the primary completion date is 11 months away. Not far out IMO.
Whether or not clinical trials can ultimately jump to an even faster track to market remains an open ended question IMO. All IN All...I believe we (Longs) are well positioned as things unfold. Based on the technology we have acquired, with limited competition (if any), the current valuation of Breathtec is ridiculously low. The Medical Device market (USA only) exceeds $170 Billion, and $400 Billion worldwide! Our medical devices will be a 1st To Market Disruptor - Period! Thanks for the heads-UP ILuvblo2.
"The company that is first to the market with a new product, especially if it can obtain a patent, can win substantial market share. Patents are important to protect key design elements that make the product unique and deserving of a premium price. Companies that receive a premium price for their products generate higher margins, which in turn give investors a superior return on their money."